Herlev Hospital

Patent Applications and Registrations

Patent applications and USPTO patent grants for Herlev Hospital.The latest application filed is for "general detection and isolation of specific cells by binding of labeled molecules".

Company Profile

6.10.14

Herlev Hospital - Herlev DK

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
General detection and isolation of specific cells by binding of labeled molecules Grant 11,402,373 - Pedersen , et al. August 2, 2	2022-08-02
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules App 20220205984 - PEDERSEN; Henrik ; et al.	2022-06-30
Vaccine Compositions Comprising Tryptophan 2,3-dioxygenase Or Fragments Thereof App 20210023191 - Andersen; Mads Hald	2021-01-28
Vaccine compositions comprising tryptophan 2,3-dioxygenase or fragments thereof Grant 10,736,950 - Andersen A	2020-08-11
Vaccine Compositions Comprising C-c Motif Chemokine 22 (ccl22) Or Fragments Thereof App 20190008939 - Andersen; Mads Hald	2019-01-10
General Detection and Isolation of Specific Cells by Binding of Labeled Molecules App 20180180601 - PEDERSEN; Henrik ; et al.	2018-06-28
Therapeutic applications of calcium electroporation to effectively induce tumor necrosis Grant 9,943,599 - Gehl , et al. April 17, 2	2018-04-17
Determining Antigen Recognition through Barcoding of MHC Multimers App 20170343545 - HADRUP; Sine Reker ; et al.	2017-11-30
Vaccine Compositions Comprising Tryptophan 2,3-dioxygenase Or Fragments Thereof App 20170239337 - Andersen; Mads Hald	2017-08-24
PD-L1 based immunotherapy Grant 9,669,078 - Andersen June 6, 2	2017-06-06
Micrornas For Prediction Of Treatment Efficacy And Prognosis Of Cancer Patients App 20150152503 - Boisen; Mogens Karsbol ; et al.	2015-06-04
Therapeutic Applications Of Calcium Electroporation To Effectively Induce Tumor Necrosis App 20150065946 - Gehl; Karen Julie ; et al.	2015-03-05
Microrna For Diagnosis Of Pancreatic Cancer And/or Prognosis Of Patients With Pancreatic Cancer By Blood Samples App 20150011414 - Johansen; Julia Sidenius ; et al.	2015-01-08
Pd-l1 Based Immunotherapy App 20140242101 - Andersen; Mads Hald	2014-08-28
Microrna Biomarkers For Prognosis Of Patients With Pancreatic Cancer App 20140106985 - Johansen; Julia Sidenius ; et al.	2014-04-17
YKL-40 as a general marker for non-specific disease Grant 8,697,384 - Johansen , et al. April 15, 2	2014-04-15
YKL-40 as a marker for gastrointestinal cancers Grant 8,580,520 - Johansen , et al. November 12, 2	2013-11-12
Indoleamine 2,3-dioxygenase Based Immunotherapy App 20110318372 - Andersen; Mads Hald ; et al.	2011-12-29
Ykl-40 As A General Marker For Non-specific Disease App 20110045518 - Johansen; Julia ; et al.	2011-02-24

Company Registrations

NCAGE Code	R2372	HERLEV HOSPITAL
CAGE Code	R2372	HERLEV HOSPITAL

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.